Immune Response Linked to 'Cancer Miracles' Says Forbes Magazine

[Guest guest]

Immune Response Linked to 'Cancer Miracles' Says Forbes Magazine Cover

Story

http://www.forbes.com/forbes/2009/0302/074_cancer_miracles.html

[Within the article, click on Six Miracle Cancer Survivors to read

stories like the following]

Sharon Belvin, the stage IV metastatic melanoma survivor given only

months to live who then recovered completely after treatment with an

immune modulator called anti-CTLA-4, is featured on the cover of the

March 2, 2009, issue of Forbes magazine. Her story is told in a

feature article penned by author Langreth titled, " Cancer

Miracles: Why Do Some People Beat the Odds? " In the article, Langreth

shares the stories of several cancer patients diagnosed with

inoperable liver cancer, late-stage melanoma, and metastatic breast

cancer, and how treatment with immunotherapies pulled them back from

the brink of death. Such recoveries, Langreth writes, though atypical,

offer crucial clues to fighting cancer. The story offers a compelling

case for the hope of cancer immunotherapy and the necessity to

continue pressing forward with out efforts to understand the immune

system and its relationship to cancer.